BROWSE·page 4 of 28

Browse EX-10 agreements

327 matching material contract exhibits.


FORM OF INDEMNIFICATION AGREEMENT

Tigerless AI Holdings Inc.

INDEMNIFICATION AGREEMENT

This **INDEMNIFICATION AGREEMENT **(this “Agreement”), dated as of the date set forth on the signature page hereto, is made by and between Tigerless AI Holdings Inc., a Nevada corporation (the “Company”), and the person set forth under the caption “Indemnitee” on the signature page hereto (“Indemnitee”).

WHEREAS, the Board of Directors of the Company (“Board”) has determined that the ability to attract and retain qualified officers, directors, employees and agents is in the best interests of the Company’s shareholders; and

WHEREAS, it is reasonable, prudent and necessary for the Company to obligate itself contractually to indemnify such persons to the fullest extent permitted by applicable law so that such persons will serve or continue to serve the Company free from undue concern that they will not be adequately indemnified; and

…

EX-10.1·S-4·CIK 2125566·ACC 0001477932-26-006037·Filed Oct 02, 2026, 19:19 ET

PROMISSORY NOTE DATED JANUARY 15, 2026

Tigerless AI Holdings Inc.

PROMISSORY* *NOTE

Principal Amount: Up to $500,000 As of January 15th, 2026

Tigerless Health Inc (“Maker”) promises to pay to the order of First Cover, Inc. (“Holder”) the principal up to Five Hundred Thousand Dollars ($500,000) or such lesser amount as shall have been loaned by Holder to Maker in lawful money of the United States of America, on the terms and conditions described below.

1.  Principal.

(a)  The principal amount outstanding under this Note shall be payable on the  earliest to occur of (i) the consummation of the Company’s initial business combination, (ii) the liquidation of the Company, or (iii) January 15, 2027 (the “Maturity Date”). Notwithstanding anything to the contrary herein, in no event shall the maturity of this Note extend beyond the Maturity Date. The Company may repay this Note, in whole or in part, at any time without premium or penalty.

…

EX-10.6·S-4·CIK 2125566·ACC 0001477932-26-006037·Filed Oct 02, 2026, 19:19 ET

FORM OF LOCK-UP AGREEMENT

Tigerless AI Holdings Inc.


LOCK-UP AGREEMENT

This Lock-up Agreement (this “Agreement”) is dated as of [●] by and among Tigerless AI Holdings Inc., a Nevada corporation (“Pubco”), Piermont Valley Acquisition Corp., an exempted company incorporated in the Cayman Islands with limited liability (“Piermont”), Tigerless Health, Inc., a New York corporation (“Tigerless”), and each of the undersigned shareholders (each a “Holder” and collectively the “Holders”) who are shareholders of Piermont or Tigerless. Pubco, Piermont, Tigerless and the Holders are collectively referred to herein as the “Parties.”

Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement and Plan of Merger, dated as of April 17, 2026 (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Business Combination Agreement”), by and among Pubco, Tigerless, Piermont, Tigerless Merger Sub 1 Corp. (“Merger Sub 1”) and Tigerless Merger Sub 2 Corp. (“Merger Sub 2”).

BACKGROUND

…

EX-10.3·S-4·CIK 2125566·ACC 0001477932-26-006037·Filed Oct 02, 2026, 19:19 ET

SECURITIES PURCHASE AGREEMENT

Tigerless AI Holdings Inc.

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of September 30, 2026 (the “Execution Date”), by and among (i) Tigerless AI Holdings Inc., a Nevada corporation (“Pubco” and, from and after the Merger Closing, the “Company”), (ii) Piermont Valley Acquisition Corp., a Cayman Islands exempted company (“Piermont”), (iii) Tigerless Health, Inc., a New York corporation (“Tigerless” and, together with Piermont and Pubco, the “Seller Parties”), and (iv) the purchaser identified on the signature page hereto (including its successors and permitted assigns, the “Purchaser”). The Seller Parties and the Purchaser are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

RECITALS

…

EX-10.9·S-4·CIK 2125566·ACC 0001477932-26-006037·Filed Oct 02, 2026, 19:19 ET

EXHIBIT 10.26

John Marshall Bancorp, Inc.

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), dated as of September 7, 2026, is made by and between John Marshall Bancorp, Inc. (the “Company”) and John Marshall Bank (the “Bank”) (collectively, “Employer”) and Kent D. Carstater (“Executive”).

WHEREAS, pursuant to that certain Agreement and Plan of Merger, dated as of September 7, 2026, by and among the Company, George Sub, Inc. (“Merger Sub”) and Eagle Financial Services, Inc. (“Seller”), it is proposed that (i) Seller will merge with and into Merger Sub, with Merger Sub as the surviving corporation (the “Intermediate Surviving Corporation”) and immediately thereafter the Intermediate Surviving Corporation will merge with and into the Company, with the Company as the surviving corporation and (ii) Bank of Clarke (“Seller Bank”) will merge with and into the Bank, with the Bank as the surviving bank (the “Transaction”);

…

EX-10.26·S-4·CIK 1710482·ACC 0001104659-26-113340·Filed Oct 02, 2026, 16:58 ET

EXHIBIT 10.25

John Marshall Bancorp, Inc.

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), dated as of September 7, 2026, is made by and between John Marshall Bancorp, Inc. (the “Company”) and John Marshall Bank (the “Bank”) (collectively, “Employer”) and Christopher W. Bergstrom (“Executive”).

WHEREAS, pursuant to that certain Agreement and Plan of Merger, dated as of September 7, 2026, by and among the Company, George Sub, Inc. (“Merger Sub”) and Eagle Financial Services, Inc. (“Seller”), it is proposed that (i) Seller will merge with and into Merger Sub, with Merger Sub as the surviving corporation (the “Intermediate Surviving Corporation”) and immediately thereafter the Intermediate Surviving Corporation will merge with and into the Company, with the Company as the surviving corporation and (ii) Bank of Clarke (“Seller Bank”) will merge with and into the Bank, with the Bank as the surviving bank (the “Transaction”);

…

EX-10.25·S-4·CIK 1710482·ACC 0001104659-26-113340·Filed Oct 02, 2026, 16:58 ET

EXHIBIT 10.27

John Marshall Bancorp, Inc.

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), dated as of September 7, 2026, is made by and between John Marshall Bancorp, Inc. (the “Company”) and John Marshall Bank (the “Bank”) (collectively, “Employer”) and Andrew Peden (“Executive”).

WHEREAS, pursuant to that certain Agreement and Plan of Merger, dated as of September 7, 2026, by and among the Company, George Sub, Inc. (“Merger Sub”) and Eagle Financial Services, Inc. (“Seller”), it is proposed that (i) Seller will merge with and into Merger Sub, with Merger Sub as the surviving corporation (the “Intermediate Surviving Corporation”) and immediately thereafter the Intermediate Surviving Corporation will merge with and into the Company, with the Company as the surviving corporation and (ii) Bank of Clarke (“Seller Bank”) will merge with and into the Bank, with the Bank as the surviving bank (the “Transaction”);

…

EX-10.27·S-4·CIK 1710482·ACC 0001104659-26-113340·Filed Oct 02, 2026, 16:58 ET

EX-10.18

ENDRA Life Sciences Inc.

FIFTH ADDENDUM TO THE TERM LOAN FACILITY AGREEMENT

Between

ASP ISOTOPES INCORPORATED

("ASPI")

and

ASP ISOTOPES SOUTH AFRICA PROPRIETARY LIMITED

("Lender")

and

RENERGEN LIMITED

("Borrower")

each hereinafter referred to individually as a Party and collectively as the Parties.


Table of Contents

Table of Contents
1. DEFINITIONS AND INTERPRETATION 3
2. INTRODUCTION 3
3. AMENDMENT 4
4. CONFLICT 4
5. COUNTERPARTS 4
6. GENERAL 4
7. SIGNATURE 5

2


WHEREBY the Parties agree as follows -

1.

…

EX-10.18·S-4·CIK 1681682·ACC 0001193125-26-410883·Filed Oct 01, 2026, 17:33 ET

EX-10.42

ENDRA Life Sciences Inc.

Nicholas M. Mitchell

Via E-mail

September22, 2026

Dear Nick,

Re: LETTER OF APPOINTMENT

We have pleasure in confirming the terms and conditions under you will continue to be employed in the position ofChief Operating Officer at Renergen Limited (or any successor corporation thereto) (the Company). This LOA and the Conditions (each, as defined below) shall supersede and replace, effective as of the date hereof (Effective Date), any and all prior or contemporaneous agreements between the parties with regard to the subject matter contained herein.

Background:

…

EX-10.42·S-4·CIK 1681682·ACC 0001193125-26-410883·Filed Oct 01, 2026, 17:33 ET

EX-10.43

ENDRA Life Sciences Inc.

THIS EMPLOYMENT AGREEMENT is made on 18th of August 2026

BETWEEN:

(1)

NOBLE AFRICA LLC, a Delaware limited liability company, whose business address is at 2200 Ross Avenue, Suite 4575E, Dallas, TX 75201, Untied States (the “Company”/ “we”/ “us”), and

(2)

JEREMY PATULLOwith an address of Studio House, The Street, Rotherwick, Hook, RG27 9BG, United Kingdom (“Executive”/ “you”).

IT IS AGREEDas follows:

Background:

The Company is a newly formed, wholly-owned subsidiary of ASP Isotopes Inc., a Delaware corporation (“ASPI”). Renergen Limited, a company incorporated under the laws of the Republic of South Africa (“Renergen”), is a wholly-owned subsidiary of ASPI whose principal asset is its 94.5% equity ownership in Tetra4 Proprietary Limited (“Tetra4”). Tetra4 holds an onshore petroleum production right and engages in the production and liquefaction of natural gas and the exploration and development of helium resources at the Virginia Gas Plant located in Free State Province, South Africa.

…

EX-10.43·S-4·CIK 1681682·ACC 0001193125-26-410883·Filed Oct 01, 2026, 17:33 ET

EX-10.10

ENDRA Life Sciences Inc.

SIDE LETTER AGREEMENT

May 26, 2026

Side Letter Agreement — PIPE Financing

Ladies and Gentlemen:

This Side Letter Agreement (this “Side Letter”) is entered into as of the date set forth above by and between ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), and LHE LNG Holdings LLC, a Delaware limited liability company (“Investor”), in connection with the matters set forth below. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Securities Purchase Agreement (as defined below).

RECITALS

…

EX-10.10·S-4·CIK 1681682·ACC 0001193125-26-410883·Filed Oct 01, 2026, 17:33 ET

EX-10.17

ENDRA Life Sciences Inc.

FOURTH ADDENDUM TO THE TERM LOAN FACILITY AGREEMENT

Between

ASP ISOTOPES INCORPORATED

("ASPI")

and

ASP ISOTOPES SOUTH AFRICA PROPRIETARY LIMITED

("Lender")

and

RENERGEN LIMITED

("Borrower")

each hereinafter referred to individually as a Party and collectively as the Parties.


Table of Contents

Table of Contents
1. DEFINITIONS AND INTERPRETATION 3
2. INTRODUCTION 3
3. AMENDMENT 3
4. CONFLICT 4
5. COUNTERPARTS 4
6. GENERAL 4
7. SIGNATURE 4

2


WHEREBY the Parties agree as follows -

1.

DEFINITIONS AND INTERPRETATION

1.1.

…

EX-10.17·S-4·CIK 1681682·ACC 0001193125-26-410883·Filed Oct 01, 2026, 17:33 ET